Dr. Reddy's Laboratories Ltd. | DRREDDY | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
141,961142,810154,482175,170190,475
Cost of revenue
Cost of revenue
-34,449-40,395-44,948-55,544-60,789
Gross Profit
Gross Profit
107,512
102,415
109,534
119,626
129,686
Sales, general & ad...
Sales, general and administrative
-80,274-78,903-77,752-78,155-84,219
Depreciation
Depreciation and amortization
-10,266-10,772-11,348-11,631-19,056
Provision
Provision
000-16,7670
Other op inc/exp...
Other operating income/expenses
-2,5160000
Operating income
Operating income EBIT
14,456
12,740
20,434
13,073
26,411
 
      
Interest expense
Interest expense
-634-788-889-983-970
Other income/exp...
Other income(expense)
1,7151,5523,3756,2062,914
Profit before tax
Profit before tax
15,537
13,504
22,920
18,296
28,355
Income tax & other ta...
Income tax and other taxes
2,6164,3803,858-1,4039,319
Net income from c...
Net income from continuing operations
12,9219,12419,06219,69919,036
Extraordinary & disc...
Extraordinary items & Discontinued Ops
00000
Share of associates
Share of associates
0344438561480
Minority Interest
Minority Interest
00000
Net Income
Net income
12,921
9,468
19,500
20,260
19,516
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
12,9219,46819,50020,26019,516
Basic shares
Basic shares
167166166166166
Diluted Shares
Diluted Shares
167166166166166
EPS Basic
EPS Basic in Rupees
77.5357.09117.53122.23117.74
EPS Diluted
EPS Diluted in Rupees
77.37
56.97
117.33
121.99
117.51